About Sony Biotechnology

  • A Message from Sony Biotechnology Regarding the COVID-19 Situation

    Sony Biotechnology is closely monitoring the COVID-19 situation across the globe. Our first priority is to ensure the health and safety of our employees in affected areas around the world. We are reviewing guidance from the World Health Organization (WHO), US Centers for Disease Control and Prevention (CDC), government agencies, and health officials in a variety of affected countries.


  • Sony MA900 Cell Sorter Nominated for Best New Life Sciences Product of 2018!

    The Sony MA900 Multi-Application Cell Sorter has been nominated for the Best New Life Sciences Product of 2018 in the Scientists' Choice Awards.


  • Cystic Fibrosis Foundation Therapeutics in Boston BizJournal

    The Cystic Fibrosis Foundation Therapeutics Inc. has opened a new laboratory in Lexington, MA. and will be using the Sony SH800 for cell sorting. The lab will focus on the discovery of promising drugs for both common and rare mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.